Literature DB >> 1832672

Characterization of the cytoplasmic proline-directed protein kinase in proliferative cells and tissues as a heterodimer comprised of p34cdc2 and p58cyclin A.

F L Hall1, R K Braun, K Mihara, Y K Fung, N Berndt, D A Carbonaro-Hall, P R Vulliet.   

Abstract

Site-specific analysis of tyrosine hydroxylase phosphorylation in rat pheochromocytoma led previously to the identification of a novel growth factor-sensitive serine/threonine protein kinase, designated proline-directed protein kinase (PDPK). In this article we describe further the activation, purification, subunit configuration, and biochemical characteristics of this cytoplasmic enzyme system. In human A431 epidermoid carcinoma cells PDPK activity was found to be stimulated by epidermal growth factor in a dose-dependent, time-dependent manner. The PDPK purified from the cytosol of mouse FM3A mammary carcinoma cells exhibited the same chromatographic behavior and biochemical properties as the tyrosine hydroxylase-associated enzyme purified originally from rat pheochromocytoma. The presence of p34cdc2 was ultimately detected in all active fractions of highly purified PDPK by Western blotting and immunoprecipitation; however, it was determined that this catalytic subunit is complexed with a 58-kDa regulatory subunit that is clearly distinct from that of the "growth-associated" M phase-specific histone H1 kinase (i.e. cyclin B). The 58 kDa regulatory subunit of PDPK was identified by direct immunoblotting as a mammalian A-type cyclin. Furthermore, the p58cyclin A subunit of PDPK was found to be phosphorylated on tyrosine residues in vivo and in vitro, the latter of which resulted in a significant increase in PDPK activity. Additional distinctions between this growth factor-sensitive PDPK (p34cdc2-p58cyclin A) and the M phase-specific histone H1 kinase (p34cdc2-p62cyclin B-p13suc1) are identified on the basis of chromatographic behavior, enzyme kinetics, and physicochemical properties. Based on these findings, it is proposed that PDPK represents a unique complex of the p34cdc2 protein kinase which is active in the cytoplasm of proliferative cells, is regulated differently from the M phase-specific histone H1 kinase by phosphorylation reactions, and is modulated selectively by growth factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832672

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases.

Authors:  M Dohadwala; E F da Cruz e Silva; F L Hall; R T Williams; D A Carbonaro-Hall; A C Nairn; P Greengard; N Berndt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

2.  Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase.

Authors:  Gina L Cano-Monreal; John E Tavis; Lynda A Morrison
Journal:  Virology       Date:  2008-01-22       Impact factor: 3.616

3.  Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex).

Authors:  Z Yao; C Grose
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.

Authors:  Janice W Kansy; S Colette Daubner; Akinori Nishi; Naoki Sotogaku; Michael D Lloyd; Chan Nguyen; Lin Lu; John W Haycock; Bruce T Hope; Paul F Fitzpatrick; James A Bibb
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

5.  Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase.

Authors:  M Ye; K M Duus; J Peng; D H Price; C Grose
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle.

Authors:  S J Elledge; R Richman; F L Hall; R T Williams; N Lodgson; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Multiple mechanisms for the phosphorylation of C-terminal regulatory sites in rabbit muscle glycogen synthase expressed in COS cells.

Authors:  A V Skurat; P J Roach
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

8.  Anisomycin and rapamycin define an area upstream of p70/85S6k containing a bifurcation to histone H3-HMG-like protein phosphorylation and c-fos-c-jun induction.

Authors:  E Kardalinou; N Zhelev; C A Hazzalin; L C Mahadevan
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs.

Authors:  S Ferrari; W Bannwarth; S J Morley; N F Totty; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Interplay between REST and nucleolin transcription factors: a key mechanism in the overexpression of genes upon increased phosphorylation.

Authors:  Teeo Tediose; Martin Kolev; Baalasubramanian Sivasankar; Paul Brennan; B Paul Morgan; Rossen Donev
Journal:  Nucleic Acids Res       Date:  2010-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.